Concurrent manifestations of primary extramammary Paget’s disease involving the left axilla and the left groin with nodal and bone metastasis

Authors

  • Thitipat Yooyuenyong Department of Dermatology, Phramongkutklao Hospital, Bangkok, Thailand.
  • Anakaporn Tiyawatanaroj Department of Dermatology, Phramongkutklao Hospital, Bangkok, Thailand.

Keywords:

Apocrine, intertrigo, metastasis, skin cancer, Toker cell

Abstract

Primary extramammary Paget's disease (EMPD) is a rare type of skin cancer, as a less aggressive intraepithelial adenocarcinoma. Patients usually present with skin lesions at apocrine gland sites such as the vulva, penoscrotal area, perianal area, umbilical area, and, less commonly, the axilla. EMPD is primarily an intraepidermal neoplasm but has the potential to invade deeper structures and metastasis. This case report presented a patient diagnosed with concurrent sites of primary EMPD, with one site showing nodal and bone metastasis. Making an accurate diagnosis of EMPD can be challenging as case occurrences are rare.

References

St. Claire K, Hoover A, Ashack K, Khachemoune A. Extramammary Paget disease. Dermatol Online J 2019;25:1-12.

Ishizuki S, Nakamura Y. Extramammary Paget's disease: diagnosis, pathogenesis, and treatment with focus on recent developments. Curr. Oncol. 2021;28:2969-2986.

Zhao C, Zhang G, Li Y, et al. Concurrent extramammary Paget's disease involving the genitalia and axilla: Case report and literature review. Australas J Dermatol 2022;63:e226-30.

Shepherd V, Davidson EJ, Davies-Humphreys J. Extramammary Paget's disease. BJOG. 2005;112:273-279.

Reddy IS, Swain M, Gowrishankar S, Murthy DBN. Primary extramammary Paget's disease with extensive skeletal metastases. Indian J Dermatol Venereol Leprol 2012;78:89-92.

Isrow D, Oregel KZ, Cortes J, et al. Advanced extramammary Paget’s disease of the groin, penis, and scrotum. Clin Med Insights Oncol 2014;8:87-90.

McDaniel B, Brown F, Crane JS. Extramammary Paget disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [Updated 2023 Jul 31; cited 2024 May 5]. Available form: https:// www.ncbi.nlm.nih.gov/books/NBK493224/

Merritt BG, Degesys CA, Brodland DG. Extramammary Paget disease. Dermatol Clin 2019;37:261-7.

Lau J, Kohler S. Keratin profile of intraepidermal cells in Paget's disease, extramammary Paget's disease, and pagetoid squamous cell carcinoma in situ. J Cutan Pathol 2003;30:449-54.

Kado S, Kamiya K, Meijuan Jin, et al. GATA-binding protein 3 and gross cystic disease fluid protein 15 as a potential diagnostic marker for extramammary Paget's disease. J Cutan Immunol Allergy 2021;4:154-8.

Morris CR, Hurst EA. Extramammary Paget's disease: A review of the literature part II: Treatment and prognosis. Dermatol Surg. 2020;46:305-11.

Yin X, Li X, Li M, et al. Treatment of Metastatic Primary Extramammary Paget Disease With Combination Anlotinib and Tislelizumab: A Case Report and Review of the Literature. Frontiers in Medicine. 2022;9:891958.

Downloads

Published

2025-11-06

How to Cite

Yooyuenyong, T., & Tiyawatanaroj, A. (2025). Concurrent manifestations of primary extramammary Paget’s disease involving the left axilla and the left groin with nodal and bone metastasis. Thai Journal of Dermatology, 41(4), 95–100. retrieved from https://he02.tci-thaijo.org/index.php/TJD/article/view/270405